DataVXJournal of Materials SciencePaper
journal article·2024-01Open access

Facet-dependent magnetic properties of magnetite nanoparticles coated with dodecyl amine and their biological effect in hepatocarcinoma cell line

Yareli Rojas-Aguirre, Juan Rizo, Miguelina Martínez-Aguilera, Adriana Rodríguez-Hernández, Beatriz Díaz-Bello, Genaro Vázquez-Victorio, Héctor Domínguez, Rubén Mendoza-Cruz, Israel Betancourt, Saret Ortega-Galindo, Patricia Guadarrama

Journal of Materials Science· Volume 59· Issue 3
Publisher pageOpen full text
Source abstract

Abstract

Abstract Herein was conducted a compelling structural analysis of magnetite nanoparticles (NPs) coated with dodecyl amine (DDA), compared with uncoated magnetite, both previously synthesized by an accelerated one-pot synthesis, starting from a single iron precursor. XRD/TEM results for the obtained nanomaterial Fe3O4@DDA showed the predominance of Fe3+ cations on the most stable atomic plane of magnetite (111). Using Molecular Dynamics calculations, with the observed atomic dispositions as inputs, it was established that NPs' surface and DDA might interact by short-distance coordination, with DDA as a ligand of Fe3+ cations, or by long-distance adsorption via H-bonding. The simulations align with TEM images, revealing an amorphous contour corresponding to the organic coating arranged as a bilayer. The TGA analysis corroborated a dual mass loss profile relating to the DDA bilayer at 116 °C and 350 °C. The Fe3O4@DDA NPs’ magnetic properties (saturation magnetization (Ms) and coercivity field (Hc)) were preserved. Fe3O4@DDA exhibited a reduction of 3 emu/g in Ms and an increment of 12 Oe in Hc, compared with Fe3O4 NPs, attributable to the coating inhomogeneity and the consequent anisotropy rise. Fe3O4@DDA triggered concentration-dependent cytotoxic effects on the human hepatocarcinoma cell line HepG2. At 50 µg/mL after incubation of 48 h, cell viability was 63% < , whereas at 72 h only 30% of cells were viable. At 300 µg/mL, less than 10% of HepG2 cells remained viable after 24 h of incubation. In the case of Fe3O4 NPs assessed in the same cell line, cell viability remained as high as 80% at 300 µg/mL during 72 h of incubation. Trypan blue assay suggests membrane integrity damage as the primary mechanism of HepG2 cell death. Even though the in vitro results herein presented are preliminary, they represent the first report of the cytotoxic effect of magnetite coated with a nitrogenous surfactant. Graphical abstract
Source: crossref · Quality: baseline

Research context

Nanomaterials

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanomaterials for catalytic reactions · Iron oxide chemistry and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (63)

Show source-provided references
1. Niculescu A-G, Chircov C, Grumezescu AM (2022) Magnetite nanoparticles: synthesis methods–a comparative review. Methods 199:16–27. https://doi.org/10.1016/j.ymeth.2021.04.01810.1016/j.ymeth.2021.04.018 ↗
2. Jjagwe J, Olupot PW, Carrara S (2023) Iron oxide nanoparticles/nanocomposites derived from steel and iron wastes for water treatment: a review. J Environ Manage 343:118236. https://doi.org/10.1016/j.jenvman.2023.11823610.1016/j.jenvman.2023.118236 ↗
3. Ng N, Wan Ibrahim WA, Sutirman ZA et al (2023) Magnetic nanomaterials for preconcentration and removal of emerging contaminants in the water environment. Nanotechnol Environ Eng 8:297–315. https://doi.org/10.1007/s41204-022-00296-410.1007/s41204-022-00296-4 ↗
4. Kumar NS, Suvarna RP, Babu Naidu KC, Reddy BVS (2022) Magnetic nanoparticles for high energy storage applications. Fundamentals and Industrial Applications of Magnetic Nanoparticles. Elsevier, Amsterdam, pp 601–61810.1016/B978-0-12-822819-7.00006-5 ↗
5. Praharaj S, Rout D (2022) Magnetic nanoparticles in catalysis industry. Fundamentals and Industrial Applications of Magnetic Nanoparticles. Elsevier, Amsterdam, pp 477–49510.1016/B978-0-12-822819-7.00022-3 ↗
6. Balaban Hanoglu S, Harmanci D, Ucar N et al (2023) Recent approaches in magnetic nanoparticle-based biosensors of miRNA detection. Magnetochemistry 9:23. https://doi.org/10.3390/magnetochemistry901002310.3390/magnetochemistry9010023 ↗
7. Adampourezare M, Hasanzadeh M, Hoseinpourefeizi MA, Seidi F (2023) Iron/iron oxide-based magneto-electrochemical sensors/biosensors for ensuring food safety: recent progress and challenges in environmental protection. RSC Adv 13:12760–1278010.1039/D2RA07415J ↗
8. Setia A, Mehata AK, Vikas, et al (2023) Theranostic magnetic nanoparticles: synthesis, properties, toxicity, and emerging trends for biomedical applications. J Drug Deliv Sci Technol 81:104295. https://doi.org/10.1016/j.jddst.2023.10429510.1016/j.jddst.2023.104295 ↗
9. Alphandéry E (2020) Iron oxide nanoparticles for therapeutic applications. Drug Discov Today 25:141–149. https://doi.org/10.1016/j.drudis.2019.09.02010.1016/j.drudis.2019.09.020 ↗
10. Jing X, Zhang Y, Li M et al (2023) Surface engineering of colloidal nanoparticles. Mater Horiz 10:1185–1209. https://doi.org/10.1039/D2MH01512A10.1039/D2MH01512A ↗
11. Hazra C, Kundu D, Chatterjee A (2018) Stimuli-responsive nanocomposites for drug delivery. Appl Nanocompos Mater Drug Deliv. https://doi.org/10.1016/B978-0-12-813741-3.00036-410.1016/B978-0-12-813741-3.00036-4 ↗
12. Aslam H, Shukrullah S, Naz MY et al (2022) Current and future perspectives of multifunctional magnetic nanoparticles based controlled drug delivery systems. J Drug Deliv Sci Technol 67:102946. https://doi.org/10.1016/J.JDDST.2021.10294610.1016/J.JDDST.2021.102946 ↗
13. Gambhir RP, Rohiwal SS, Tiwari AP (2022) Multifunctional surface functionalized magnetic iron oxide nanoparticles for biomedical applications: a review. Appl Surf Sci Adv. https://doi.org/10.1016/j.apsadv.2022.10030310.1016/j.apsadv.2022.100303 ↗
14. Abdolrahimi M, Vasilakaki M, Slimani S et al (2021) Magnetism of nanoparticles: effect of the organic coating. Nanomaterials 11:1787. https://doi.org/10.3390/nano1107178710.3390/nano11071787 ↗
15. Lima E, Brandl AL, Arelaro AD, Goya GF (2006) Spin disorder and magnetic anisotropy in Fe3 O4 nanoparticles. J Appl Phys DOI. https://doi.org/10.1063/1.219147110.1063/1.2191471 ↗
16. Cruz-Vargas J, Belmont-Bernal F, Vera-De La Garza CG et al (2018) Accelerated one-pot synthesis of coated magnetic nanoparticles from iron(ii) as a single precursor. New J Chem 42:13107–13113. https://doi.org/10.1039/c8nj02270d10.1039/c8nj02270d ↗
17. Vestal CR, Zhang ZJ (2003) Effects of surface coordination chemistry on the magnetic properties of MnFe2O4 spinel ferrite nanoparticles. J Am Chem Soc. https://doi.org/10.1021/ja035474n10.1021/ja035474n ↗
18. Yuan Y, Rende D, Altan CL et al (2012) Effect of surface modification on magnetization of iron oxide nanoparticle colloids. Langmuir. https://doi.org/10.1021/la302247910.1021/la3022479 ↗
19. Nikolova MP, Joshi PB, Chavali MS (2023) Updates on biogenic metallic and metal oxide nanoparticles: therapy. Drug Deliv Cytotox Pharm 15:1650. https://doi.org/10.3390/pharmaceutics1506165010.3390/pharmaceutics15061650 ↗
20. Frtús A, Smolková B, Uzhytchak M et al (2020) Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: a road from failure to success in clinical applications. J Control Release 328:59–77. https://doi.org/10.1016/j.jconrel.2020.08.03610.1016/j.jconrel.2020.08.036 ↗
21. Dragar Č, Kralj S, Kocbek P (2021) Bioevaluation methods for iron-oxide-based magnetic nanoparticles. Int J Pharm 597:120348. https://doi.org/10.1016/j.ijpharm.2021.12034810.1016/j.ijpharm.2021.120348 ↗
22. Lunova M, Smolková B, Lynnyk A et al (2019) Targeting the mTOR signaling pathway utilizing nanoparticles: a critical overview. Cancers (Basel) 11:82. https://doi.org/10.3390/cancers1101008210.3390/cancers11010082 ↗
23. Zavisova V, Koneracka M, Kovac J et al (2015) The cytotoxicity of iron oxide nanoparticles with different modifications evaluated in vitro. J Magn Magn Mater 380:85–89. https://doi.org/10.1016/j.jmmm.2014.10.04110.1016/j.jmmm.2014.10.041 ↗
24. Tran N, Webster TJ (2010) Magnetic nanoparticles: biomedical applications and challenges. J Mater Chem 20:8760. https://doi.org/10.1039/c0jm00994f10.1039/c0jm00994f ↗
25. Konuk M, Sellschopp K, Vonbun-Feldbauer GB, Meißner RH (2021) Modeling charge redistribution at magnetite interfaces in empirical force fields. J Phys Chem C 125:4794–4805. https://doi.org/10.1021/acs.jpcc.0c1033810.1021/acs.jpcc.0c10338 ↗
26. Tombácz E, Hajdú A, Illés E et al (2009) Water in contact with magnetite nanoparticles, as seen from experiments and computer simulations. Langmuir 25:13007–13014. https://doi.org/10.1021/la901875f10.1021/la901875f ↗
27. Brown ZJ, Tsilimigras DI, Ruff SM et al (2023) Management of hepatocellular carcinoma: a review. JAMA Surg 158:410–420. https://doi.org/10.1001/jamasurg.2022.798910.1001/jamasurg.2022.7989 ↗
28. Espinosa-Jiménez H, Salazar-Arriaga AB, Dominguez H (2023) Development of a new force field for the family of primary aliphatic amines using the three steps systematic parameterization procedure. Condens Matter Phys. https://doi.org/10.5488/CMP.26.2360310.5488/CMP.26.23603 ↗
29. Berendsen HJC, Grigera JR, Straatsma TP (1987) The missing term in effective pair potentials. J Phys Chem 91:6269–6271. https://doi.org/10.1021/j100308a03810.1021/j100308a038 ↗
30. Hess B, Kutzner C, Van Der Spoel D, Lindahl E (2008) GRGMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4:435–447. https://doi.org/10.1021/ct700301q10.1021/ct700301q ↗
31. Eustaquio T, Leary JF (2016) Nanobarcoded superparamagnetic iron oxide nanoparticles for nanomedicine: Quantitative studies of cell-nanoparticle interactions by scanning image cytometry. Cytometry A 89:207–216. https://doi.org/10.1002/cyto.a.2269910.1002/cyto.a.22699 ↗
32. Wu W, Wu Z, Yu T et al (2015) Recent progress on magnetic iron oxide nanoparticles: Synthesis, surface functional strategies and biomedical applications. Sci Technol Adv Mater 16:02350110.1088/1468-6996/16/2/023501 ↗
33. Hu L, Ren X, Yang M, Guo W (2021) Facet-controlled activation of persulfate by magnetite nanoparticles for the degradation of tetracycline. Sep Purif Technol. https://doi.org/10.1016/j.seppur.2020.11801410.1016/j.seppur.2020.118014 ↗
34. Holder CF, Schaak RE (2019) Tutorial on powder x-ray diffraction for characterizing nanoscale materials. ACS Nano 13:7359–7365. https://doi.org/10.1021/acsnano.9b0515710.1021/acsnano.9b05157 ↗
35. Santos-Carballal D, Roldan A, Grau-Crespo R, de Leeuw NH (2014) A DFT study of the structures, stabilities and redox behaviour of the major surfaces of magnetite Fe3O4. Phys Chem Chem Phys 16:21082–21097. https://doi.org/10.1039/c4cp00529e10.1039/c4cp00529e ↗
36. Yang T, Wen XD, Ren J et al (2010) Surface structures of Fe3O4 (111), (110), and (001)-a density functional theory study. Ranliao Huaxue Xuebao/J Fuel Chem Technol 38:121–128. https://doi.org/10.1016/s1872-5813(10)60024-210.1016/s1872-5813(10)60024-2 ↗
37. Creutzburg M, Sellschopp K, Gleißner R et al (2022) Surface structure of magnetite (111) under oxidizing and reducing conditions. J Phys Cond Matter. https://doi.org/10.1088/1361-648X/ac4d5a10.1088/1361-648X/ac4d5a ↗
38. Horák D, Pustovyy VI, Babinskyi AV et al (2017) Enhanced antitumor activity of surface-modified iron oxide nanoparticles and an α-tocopherol derivative in a rat model of mammary gland carcinosarcoma. Int J Nanomed 12:4257–4268. https://doi.org/10.2147/IJN.S13757410.2147/IJN.S137574 ↗
39. Arora V, Sood A, Shah J et al (2017) Synthesis and characterization of pectin-6-aminohexanoic acid-magnetite nanoparticles for drug delivery. Mater Sci Eng C 80:243–251. https://doi.org/10.1016/j.msec.2017.05.09710.1016/j.msec.2017.05.097 ↗
40. Umut E, Pineider F, Arosio P et al (2012) Magnetic, optical and relaxometric properties of organically coated gold–magnetite (Au–Fe3O4) hybrid nanoparticles for potential use in biomedical applications. J Magn Magn Mater 324:2373–2379. https://doi.org/10.1016/j.jmmm.2012.03.00510.1016/j.jmmm.2012.03.005 ↗
41. Singh S, Munjal S, Khare N (2015) Strain/defect induced enhanced coercivity in single domain CoFe2O4 nanoparticles. J Magn Magn Mater 386:69–73. https://doi.org/10.1016/j.jmmm.2015.03.05710.1016/j.jmmm.2015.03.057 ↗
42. van Meerloo J, Kaspers GJL, Cloos J (2011) Cell Sensitivity Assays: The MTT Assay. In: Cree IA (ed) Cancer Cell Culture: Methods and Protocols. Humana Press, Totowa, NJ, pp 237–24510.1007/978-1-61779-080-5_20 ↗
43. Chan LL, Wilkinson AR, Paradis BD, Lai N (2012) Rapid image-based cytometry for comparison of fluorescent viability staining methods. J Fluoresc 22:1301–1311. https://doi.org/10.1007/s10895-012-1072-y10.1007/s10895-012-1072-y ↗
44. Sadeghi L, Tanwir F, Yousefi Babadi V (2015) In vitro toxicity of iron oxide nanoparticle: oxidative damages on Hep G2 cells. Exp Toxicol Pathol 67:197–203. https://doi.org/10.1016/j.etp.2014.11.01010.1016/j.etp.2014.11.010 ↗
45. Patil RM, Thorat ND, Shete PB et al (2018) Comprehensive cytotoxicity studies of superparamagnetic iron oxide nanoparticles. Biochem Biophys Rep 13:63–72
46. Qu JB, Shao HH, Jing GL, Huang F (2013) PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies. Colloids Surf B Biointerfaces 102:37–44. https://doi.org/10.1016/j.colsurfb.2012.08.00410.1016/j.colsurfb.2012.08.004 ↗
47. Sudame A, Kandasamy G, Singh D et al (2020) Symbiotic thermo-chemotherapy for enhanced HepG2 cancer treatment via magneto-drugs encapsulated polymeric nanocarriers. Colloids Surf A Physicochem Eng Asp. https://doi.org/10.1016/j.colsurfa.2020.12535510.1016/j.colsurfa.2020.125355 ↗
48. Hedayatnasab Z, Dabbagh A, Abnisa F, Wan Daud WMA (2020) Synthesis and in-vitro characterization of superparamagnetic iron oxide nanoparticles using a sole precursor for hyperthermia therapy. Mater Res Bull. https://doi.org/10.1016/j.materresbull.2020.11097510.1016/j.materresbull.2020.110975 ↗
49. Kandasamy G, Soni S, Sushmita K et al (2019) One-step synthesis of hydrophilic functionalized and cytocompatible superparamagnetic iron oxide nanoparticles (SPIONs) based aqueous ferrofluids for biomedical applications. J Mol Liq 274:653–663. https://doi.org/10.1016/j.molliq.2018.10.16110.1016/j.molliq.2018.10.161 ↗
50. Peng X, Wang B, Yang Y et al (2019) Liver tumor spheroid reconstitution for testing mitochondrial targeted magnetic hyperthermia treatment. ACS Biomater Sci Eng 5:1635–1644. https://doi.org/10.1021/acsbiomaterials.8b0163010.1021/acsbiomaterials.8b01630 ↗
51. Huang G, Diakur J, Xu Z, Wiebe LI (2008) Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles. Int J Pharm 360:197–203. https://doi.org/10.1016/j.ijpharm.2008.04.02910.1016/j.ijpharm.2008.04.029 ↗
52. Li Z, Wang X, Miao J et al (2022) Antibacterial activity of dodecylamine dialdehyde starch schiff base derivatives. Starch/Staerke. https://doi.org/10.1002/star.20210017810.1002/star.202100178 ↗
53. Koziróg A, Brycki B, Pielech-Przybylska K (2018) Impact of cationic and neutral gemini surfactants on conidia and hyphal forms of Aspergillus brasiliensis. Int J Mol Sci. https://doi.org/10.3390/ijms1903087310.3390/ijms19030873 ↗
54. Mokashi S, Kanaan J, Craft DL et al (2020) Killing of bacterial spores by dodecylamine and its effects on spore inner membrane properties. J Appl Microbiol 129:1511–1522. https://doi.org/10.1111/jam.1473210.1111/jam.14732 ↗
55. Sun J, Li M, Lin K et al (2023) Delivery of quercetin for breast cancer and targeting potentiation via hyaluronic nano micelle. Int J Biol Macromol. https://doi.org/10.1016/j.ijbiomac.2023.12473610.1016/j.ijbiomac.2023.124736 ↗
56. Yu Y, Yang X, Liu M et al (2019) Anticancer drug delivery to cancer cells using alkyl amine-functionalized nanodiamond supraparticles. Nanoscale Adv 1:3406–3412. https://doi.org/10.1039/c9na00453j10.1039/c9na00453j ↗
57. Zhang Y, Wang H, Jiang H, Wang X (2012) Water induced protonation of amine-terminated micelles for direct syntheses of ZnO quantum dots and their cytotoxicity towards cancer. Nanoscale 4:3530–3535. https://doi.org/10.1039/c2nr30127j10.1039/c2nr30127j ↗
58. Wang J, Tan W, Li G et al (2020) Enzymatic insertion of lipids increases membrane tension for inhibiting drug resistant cancer cells. Chem Eur J 26:15116–15120. https://doi.org/10.1002/chem.20200297410.1002/chem.202002974 ↗
59. Wu J, Han J, Hou B et al (2016) Sulforaphane inhibits TGF-β-induced epithelial-mesenchymal transition of hepatocellular carcinoma cells via the reactive oxygen species-dependent pathway. Oncol Rep. https://doi.org/10.3892/or.2016.463810.3892/or.2016.4638 ↗
60. Fischel’s SV, Medzihradsky F (1985) Assessment of membrane permeability in primary cultures of neurons and glia in response to osmotic perturbation. J Neurosci Res 13:369–380. https://doi.org/10.1002/jnr.49013030410.1002/jnr.490130304 ↗
61. Kamiloglu S, Sari G, Ozdal T, Capanoglu E (2020) Guidelines for cell viability assays. Food Front 1:332–349. https://doi.org/10.1002/fft2.4410.1002/fft2.44 ↗
62. Tan LTH, Chan KG, Pusparajah P et al (2017) Targeting membrane lipid a potential cancer cure? Front Pharmacol 8:1–6. https://doi.org/10.3389/fphar.2017.0001210.3389/fphar.2017.00012 ↗
63. Jendrossek V, Handrick R (2003) Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitisers10.2174/1568011033482341 ↗